TScan Therapeutics (TCRX) Stock Chart & Stock Price History $1.62 -0.12 (-6.90%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.58 -0.05 (-2.78%) As of 08/1/2025 06:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TScan Therapeutics Stock Price Performance The TScan Therapeutics (TCRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 75.86%, with a year-to-date return of -46.71%. In the past month, the stock has increased 10.20%, reflecting recent market activity. As of the latest close, TScan Therapeutics traded at $1.62 with a market cap of $91.68 million and volume of 462,376 shares. Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-13.37%1 Month Performance+10.20%3 Month Performance+1.25%Year-To-Date Performance-46.71%1 Year Performance-75.86% TCRX Stock Chart for Saturday, August, 2, 2025 TCRX Chart by TradingView TScan Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$1.74$1.62-6.90%$1.77$1.60462,376 shs$91.68 million07/31/2025$1.81$1.74-3.87%$1.87$1.72248,775 shs$98.47 million07/30/2025$1.80$1.81+0.56%$1.86$1.80175,942 shs$102.43 million07/29/2025$1.87$1.80-3.74%$1.92$1.76409,687 shs$101.86 million07/28/2025$1.93$1.87-3.11%$1.99$1.87497,911 shs$105.82 million07/25/2025$1.87$1.93+3.21%$1.95$1.78457,402 shs$109.22 million07/24/2025$1.86$1.87+0.54%$1.90$1.83240,365 shs$105.82 million07/23/2025$1.85$1.86+0.54%$1.96$1.84290,532 shs$105.26 million07/22/2025$1.83$1.85+1.09%$1.87$1.78155,524 shs$104.69 million07/21/2025$1.82$1.83+0.55%$1.87$1.75322,934 shs$103.56 million Get the Latest News and Ratings for TCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$1.89$1.82-3.70%$1.91$1.81177,988 shs$102.99 million07/17/2025$1.81$1.89+4.42%$1.94$1.80380,352 shs$106.96 million07/16/2025$1.77$1.81+2.26%$1.86$1.76304,476 shs$102.43 million07/15/2025$1.92$1.77-7.81%$1.91$1.75314,442 shs$100.17 million07/14/2025$1.81$1.92+6.08%$1.94$1.77270,869 shs$108.66 million07/11/2025$1.84$1.81-1.63%$1.86$1.76228,621 shs$102.43 million07/10/2025$1.84$1.84$1.88$1.75231,710 shs$104.13 million07/09/2025$1.70$1.84+8.24%$1.90$1.72493,368 shs$104.13 million07/08/2025$1.45$1.70+17.24%$1.73$1.46691,599 shs$96.20 million07/07/2025$1.51$1.45-3.97%$1.55$1.45342,609 shs$85.45 million07/04/2025$1.51$1.51$1.53$1.47185,958 shs$85.45 million07/03/2025$1.47$1.51+2.72%$1.53$1.47185,958 shs$85.45 million07/02/2025$1.43$1.47+2.80%$1.54$1.45222,976 shs$83.19 million07/01/2025$1.45$1.43-1.38%$1.54$1.43294,957 shs$80.92 million Related Companies Palvella Therapeutics Stock Chart Fulcrum Therapeutics Stock Chart Gossamer Bio Stock Chart Tectonic Therapeutic Stock Chart Eton Pharmaceuticals Stock Chart Aquestive Therapeutics Stock Chart Arcturus Therapeutics Stock Chart COMPASS Pathways Stock Chart SNDL Stock Chart CryoPort Stock Chart Receive TCRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for TScan Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TCRX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredDon’t Touch Tesla Stock Without Reading This FirstJeff Brown says he wouldn’t touch Tesla stock right now—and the reason might shock you. A 40-year Wall Stre...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
